Since the 2023 financing round, Flare’s lead program FX-909 has moved into a phase 1 clinical trial for patients with ...

Seventy-two years after the Roche family opened a meat market that grew into a Massachusetts supermarket chain, the family is ...

Roche Bros. Supermarkets is selling controlling interest to one of its suppliers. The family-owned retailer that operates 20 stores in Massachusetts entered into agreement with Bozzuto's Inc., a deal ...

Bring your passport with you when shopping at Citypharma Paris to be eligible for tax-free shopping. Ask for details and ...

Flare Therapeutics will lead discovery and preclinical activities targeting multiple transcription factor targets in oncology, while Roche will pursue the further preclinical and clinical development ...

Flare Therapeutics Inc., a clinical-stage biotechnology company targeting transcription factors to discover precision ...

In a report released today, Matthew Weston from UBS maintained a Hold rating on Roche Holding AG (RHHVF – Research Report), with a price target of CHF270.00. The company’s shares closed yesterday at ...

The brand, alongside a committee of board-certified dermatologists, awards winners for their research and provides grants to ...

said Roche "is committed to deliver healthcare innovations that significantly improve patients' lives in the country while ...

Alongside opening the new offices, Roche Diagnostics' capabilities in China have been further recognised as it has been ...

The European market for life science tools and reagents and COVID-19 diagnostics products was valued at $14.7 billion in 2023. The market is expected to grow from $13.0 billion in 2024 to $15.4 ...